High-dose melphalan and total body irradiation with bone marrow transplantation for refractory malignancies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High-dose melphalan and total body irradiation with bone marrow transplantation for refractory malignancies

Published:1986-06 Issue:6 Volume:22 Page:677-684
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

Spitzer G.,Jagannath S.,Dicke K.A.,Armitage J.,Zander A.R.,Vellekoop L.,Horwitz L.,Cabanillas F.,Zagars G.K.,Velasquez W.S.

Publisher

Elsevier BV

Subject

Oncology

Reference24 articles.

1. High-dose chemotherapy with autologous bone marrow transplantation;Spitzer;Cancer,1984

2. Bone marrow transplantation in lymphoma;Spitzer,1984

3. Prolonged complete remission following high dose chemotherapy of Burkitt's lymphoma in relapse;Applebaum;Cancer,1978

4. Autologous bone marrow transplantation for non-Hodgkin's lymphoma: the preliminary European experience;Goldstone,1985

5. Autologous stem cell transplant for poor prognosis diffuse histiocytic lymphoma;Gulati,1985

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Solid-State Formation of a Potential Melphalan Delivery Nanosystem Based on β-Cyclodextrin and Silver Nanoparticles;International Journal of Molecular Sciences;2023-02-16

2. Single center experience with total body irradiation and melphalan (TBI-MEL) myeloablative conditioning regimen for allogeneic stem cell transplantation (SCT) in patients with refractory hematologic malignancies;Annals of Hematology;2013-10-06

3. Autologous bone marrow transplantation therapy for multiple myeloma;European Journal of Haematology;2009-04-24

4. Long-term follow-up of patients receiving salvage chemotherapy for intermediate and high grade non-Hodgkin's lymphomas;Hematological Oncology;2006-10

5. Allogeneic bone marrow transplantation for poor-prognosis lymphoma: Response, toxicity, and survival depend on disease histology;The American Journal of Medicine;1996-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3